Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.40 | €45.10 | 145.082% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.42 | - | - |
| Repligen Corp. | 13 | 0 | 1 | 0 | €151.00 | €184.76 | 22.358% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.20 | €236.30 | 67.350% |
| Gerresheimer AG | 7 | 0 | 1 | 0 | €98.35 | €110.00 | 11.845% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €282.70 | - | - |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.80 | €65.00 | -2.695% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.56 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €28.78 | €35.99 | 25.036% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €39.08 | €50.33 | 28.794% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €165.75 | €215.54 | 30.038% |
| Horizon Pharma plc | 7 | 0 | 0 | 0 | €110.40 | - | - |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.00 | €38.99 | 25.770% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €124.00 | €150.00 | 20.968% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.50 | - | - |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €336.80 | €369.72 | 9.776% |
| Davita Inc. | 2 | 0 | 0 | 0 | €129.05 | €124.89 | -3.225% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €373.00 | €421.61 | 13.031% |
| Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €105.00 | €184.92 | 76.114% |
| Amn Healthcare Svs | 1 | 0 | 1 | 0 | €55.50 | - | - |
| Bio-Rad Labs Inc. A | 7 | 0 | 1 | 0 | €253.70 | €445.58 | 75.634% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €109.00 | €116.99 | 7.332% |
| United Therapeutics | 18 | 0 | 3 | 0 | €249.10 | €288.66 | 15.881% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.20 | - | - |